Dual antiplatelet therapy practices following Pipeline Shield embolization and their impact on adverse events in three large real-life registries
In this large real-world retrospective analysis, most major adverse events were reported within 30 days post-FDS procedure. Complications rates after discharge and after DAPT discontinuation were very low and similar between DAPT duration groups. These data provide a foundation for designing future prospective studies to evaluate optimal DAPT protocols-both in terms of drug type and duration-which could potentially inform future clinical guidelines.
Authors
- Cristian Mihalea (ORCID: https://orcid.org/0000-0002-8260-8284)
- Laurent Spelle (ORCID: https://orcid.org/0000-0002-6748-8528)
- Saleh Lamin (ORCID: https://orcid.org/0000-0002-2208-7501)
- Jildaz Caroff (ORCID: https://orcid.org/0000-0002-0029-1835)
- Markus Holtmannspötter
- Mario Martínez‐Galdámez (ORCID: https://orcid.org/0000-0002-8024-4712)
- Jens Fiehler
Institutions
- Universidad de Valladolid (ES)
- Inserm (FR)
- Universität Hamburg (DE)
- Université Paris-Saclay (FR)
- Queen Elizabeth Hospital Birmingham (GB)
- Victor Babeș University of Medicine and Pharmacy Timișoara (RO)
- University Medical Center Hamburg-Eppendorf (DE)
- Paracelsus Medizinische Privatuniversität (DE)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- Journal of Neuroradiology
- Published
- 2025-07-19
- DOI
- https://doi.org/10.1016/j.neurad.2025.101372
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00